TuisSBHMY • OTCMKTS
add
Sino Biopharmaceutical Unsponsored Caymand Islands ADR
Vorige sluiting
$9,05
Jaarwisseling
$6,69 - $9,65
Markkapitalisasie
61,24 mjd HKD
Gemiddelde volume
50,00
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
(CNY) | Jun. 2024info | J/J-verandering |
---|---|---|
Inkomste | 7,94 mjd | 11,14% |
Bedryfskoste | 4,78 mjd | 10,58% |
Netto inkomste | 1,51 mjd | 139,69% |
Netto winsgrens | 19,01 | 115,78% |
Wins per aandeel | — | — |
EBITDA | 1,98 mjd | 8,88% |
Effektiewe belastingkoers | 16,99% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
(CNY) | Jun. 2024info | J/J-verandering |
---|---|---|
Kontant en korttermynbeleggings | 13,18 mjd | -15,93% |
Totale bates | 66,70 mjd | 1,62% |
Totale aanspreeklikheid | 24,58 mjd | -15,76% |
Totale ekwiteit | 42,12 mjd | — |
Uitstaande aandele | 18,21 mjd | — |
Prys om te bespreek | 5,03 | — |
Opbrengs op bates | 6,50% | — |
Opbrengs op kapitaal | 8,37% | — |
Kontantvloei
Netto kontantverandering
(CNY) | Jun. 2024info | J/J-verandering |
---|---|---|
Netto inkomste | 1,51 mjd | 139,69% |
Kontant van bedrywe | 1,54 mjd | 15,25% |
Kontant van beleggings | -1,02 mjd | 49,91% |
Kontant van finansiering | -2,05 mjd | -1,42% |
Netto kontantverandering | -1,52 mjd | 43,37% |
Beskikbare kontantvloei | 1,09 mjd | 36,59% |
Meer oor
Sino Biopharmaceutical Limited, shortly Sino Biopharm, is a civilian-run enterprise principally engaged in the medicine products business in Mainland China.
Being a member of Charoen Pokphand Group and headquartered in Hong Kong and Beijing, Sino Biopharm is engaged in researching, developing, producing, and selling biopharmaceutical products for the medical treatment of ophthalmia, as well as modernized Chinese medicine and chemical medicine for the treatment of hepatitis through its subsidiaries.
Sino Biopharm is also involved in other minor businesses through its subsidiaries, such as properties, health food, optical glass, optical and auditory products. Wikipedia
HUB
Gestig
2000
Webwerf
Werknemers
24 437